The article explores alternative molecular mechanismsincluding tau protein aggregation, neuroinflammation, synaptic and mitochondrial dysfunction, brain insulin resistance, vascular impairment, and infectious triggersthat may provide better insights into disease progression and resistance to current treatments
A1c changes typically become apparent after 8-12 weeks on a stable dose
Regarding dosage , the Phase 2 trial investigated several dose levels administered as a once-weekly subcutaneous injection, ranging from 1 mg up to 12 mg per week , with a gradual escalation schedule
But in general, turning a peptide (including GLP-1 or insulin) into an oral formulation means overcoming three major challenges: protecting the peptide from digestion in the stomach, improving absorption of the peptide via the gut, and slowing down the enzymatic breakdown and excretion of the peptide once it is in the blood
TRPA1 receptor induced relaxation of the human urethra involves TRPV1 and cannabinoid receptor mediated signals, and cyclooxygenase activation